Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

ISLET BIOLOGY

Glucagon receptor antagonists might stimulate β-cell expansion

In a recent issue of Cell Reports, Xi et al. reported on their studies of an anti-glucagon receptor antibody in several mouse models of insulin-deficient diabetes mellitus, in which they show substantial increase in β-cell mass from enhanced replication and transdifferentiation of glucagon-expressing α-cells to insulin-expressing β-cells.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1: Glucagon receptor antagonists can lead to regeneration of β-cells in insulin-deficient mice, but their effect in humans is unclear.

References

  1. Xi, Y. et al. Glucagon-receptor-antagonism-mediated β-cell regeneration as an effective anti-diabetic therapy. Cell Rep. 39, 110872 (2022).

    CAS  Article  Google Scholar 

  2. Lee, Y. H., Wang, M. Y., Yu, X. X. & Unger, R. H. Glucagon is the key factor in the development of diabetes. Diabetologia 59, 1372–1375 (2016).

    CAS  Article  Google Scholar 

  3. Wang, M. Y. et al. Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway. Proc. Natl Acad. Sci. USA 112, 2503–2508 (2015).

    CAS  Article  Google Scholar 

  4. Gelling, R. W. et al. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc. Natl Acad. Sci. USA 100, 1438–1443 (2003).

    CAS  Article  Google Scholar 

  5. Wang, M. Y. et al. Glucagon blockade restores functional β-cell mass in type 1 diabetic mice and enhances function of human islets. Proc. Natl Acad. Sci. USA 118, e2022142118 (2021).

    CAS  Article  Google Scholar 

  6. Okamoto, H. et al. Glucagon receptor inhibition normalizes blood glucose in severe insulin-resistant mice. Proc. Natl Acad. Sci. USA 114, 2753–2758 (2017).

    CAS  Article  Google Scholar 

  7. Thorel, F. et al. Conversion of adult pancreatic α-cells to β-cells after extreme β-cell loss. Nature 464, 1149–1154 (2010).

    CAS  Article  Google Scholar 

  8. Nir, T., Melton, D. A. & Dor, Y. Recovery from diabetes in mice by beta cell regeneration. J. Clin. Invest. 117, 2553–2561 (2007).

    CAS  Article  Google Scholar 

  9. Okamoto, H. et al. Glucagon receptor blockade with a human antibody normalizes blood glucose in diabetic mice and monkeys. Endocrinology 156, 2781–2794 (2015).

    CAS  Article  Google Scholar 

  10. Scheen, A. J., Paquot, N. & Lefèbvre, P. J. Investigational glucagon receptor antagonists in phase I and II clinical trials for diabetes. Expert Opin. Investig. Drugs 26, 1373–1389 (2017).

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susan Bonner-Weir.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Rubin de Celis, M.F., Bonner-Weir, S. Glucagon receptor antagonists might stimulate β-cell expansion. Nat Rev Endocrinol (2022). https://doi.org/10.1038/s41574-022-00735-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41574-022-00735-x

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing